Home  /  Resource Library  /  Three-year follow-up of epcoritamab therapy in Japanese patients with relapsed/refractory follicular lymphoma in EPCORE NHL-3

Three-year follow-up of epcoritamab therapy in Japanese patients with relapsed/refractory follicular lymphoma in EPCORE NHL-3

Follow up study investigating epcoritamab for treatment of relapsed follicular lymphoma in Japan.